pfizer inc (PFE:New York)
Transactions by PFIZER INC (PFE) in the last 6 months
XRpro Sciences, Inc. entered into an asset purchase agreement to acquire Icagen, Inc from Pfizer Inc. (NYSE:PFE) for $11 million on June 26, 2015. Under the terms of the agreement, XRpro agreed to pay: (i) an upfront cash purchase price of $0.5 million, of which $0.125 million was paid at closing date, and $0.375 million is to be paid in three equal installments of $0.125 million, on September 1, 2015, December 1, 2015 and March 1, 2016; (ii) a cash payment of $0.5 million ...
Pfizer Inc. (NYSE:PFE) acquired 17.5% stake in AM-Pharma B.V. on May 11, 2015. Pfizer Inc. acquired minority stake and an exclusive option to acquire the remaining equity in AM-Pharma. Pfizer made an upfront payment of $87.5 million for the minority equity interest and exclusive option, with additional potential payments of up to $512.5 million upon option exercise and potential launch of any product that may result from this agreement. Clifford Chance LLP and Jonathan ...
|Allergan plc||$312.00 USD||+6.02|
|Gilead Sciences Inc||$107.99 USD||+1.03|
|Johnson & Johnson||$96.22 USD||+1.11|
|Nestle SA||SFr.70.45 CHF||-0.55|
|Procter & Gamble Co/The||$71.48 USD||+0.58|
|View Industry Companies|